Products

Biaffin

Newsletter

kinases protein kinase inhibitors signaling activators kinase substrates antibodies bioluminescence assays
Recombinant human Neprilysin /CD10 Protein, Tag free, 50µg  

Recombinant human Neprilysin /CD10 Protein, Tag free, 50µg

Recombinant Human Neprilysin / CD10 / MME Protein, Tyr 52 - Trp 750, produced in human 293 cells (HEK293), Tag free

Synonym
Recombinant Human Protein, MME, CALLA, CD10, DKFZp686O16152, MGC126681, MGC126707, NEP, SFE, Neprilysin, metalloportease

More details

MME-H521b-050

Availability: within 7 days

480,00 €

Background
Cluster of differentiation 10 (CD10), membrane metallo-endopeptidase, neutral endopeptidase (NEP), Neprilysin, and common acute lymphoblastic leukemia antigen (CALLA), is a 90-110-kDa type II transmembrane glycoprotein normally expressed by a variety of tissues, including epithelial cells of the prostate, kidney, intestine, endometrium, adrenal glands, and lung. This zinc-dependent metalloprotease enzyme cleaves peptide bonds on the amino side of hydrophobic residues and inactivates a variety of physiologically active secreted peptides. CD20 is thought to be the rate-limiting degrading enzyme of amyloid β peptide (Aβ) whose abnormal misfolding and aggregation in neural tissue has been implicated in the development of Alzheimer\'s disease (AD). CD10 is also identified as the common acute lymphoblastic leukemia antigen (CALLA) present on leukemic cells of pre-B phenotype, and thus serves as the most important biomarker in the diagnosis of human acute lymphocytic leukemia (ALL). [1-4]

Source
Recombinant Human Neprilysin, Tag Free (MME-H521b) is expressed from human 293 cells (HEK293). It contains AA Tyr 52 - Trp 750 (Accession # NP_000893.2).

Molecular Characterization
This protein carries no "tag".
The protein has a calculated MW of 80.0 kDa. The protein migrates as 80-100 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.

Endotoxin
Less than 1.0 EU per μg by the LAL method.

Purity
>95% as determined by SDS-PAGE.

Formulation
Lyophilized from 0.22 μm filtered solution in 20 mM Tris, 100 mM NaCl, pH8.0 . Normally trehalose is added as protectant before lyophilization.

Reconstitution
See Certificate of Analysis for details of reconstitution instruction and specific concentration.

Storage
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.

Clinical and Translational Updates

(1) "CAN IMPARED SYSTOLIC FUNCTION BE DETECTED FROM PRESSURE WAVEFORMS?"
Orter, Hametner, Wassertheurer et al
J Hypertens (2022) 40 (Suppl 1), e92
(2) "CARDIOVASCULAR EFFICACY OF SODIUM-GLUCOSE CO-TRANSPORTER-2 INHIBITORS AND ANGIOTENSIN RECEPTOR NEPRILYSIN INHIBITORS IN PATIENTS WITH HEART FAILURE ACCORDING TO MINERALOCORTICOID R"
Patoulias, Katsimardou, Siskos et al
J Hypertens (2022) 40 (Suppl 1), e70
(3) "New Strategies for Volume Control in Patients with Diabetes Mellitus, a Narrative Review"
Gérard, Laurain, Sicard et al
Pharmaceutics (2022) 14 (8)
Showing 1-3 of 6496 papers.